Centessa Pharmaceuticals Financial Overview
Centessa Pharmaceuticals's market cap is currently $3.97B. The company's EPS TTM is $-0.41; its P/E ratio is ―; Centessa Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
